Patient presents with suspected liver metastasis.  Presenting complaints include abdominal pain, right upper quadrant discomfort, hepatomegaly, fatigue, weight loss, and decreased appetite.  Relevant medical history includes primary cancer diagnosis of [Specify primary cancer site, e.g., colon, breast, lung].  Physical examination reveals [Describe findings, e.g., palpable liver mass, jaundice, ascites].  Laboratory findings show elevated liver enzymes (AST, ALT, ALP), elevated bilirubin, and abnormal liver function tests.  Imaging studies, including abdominal ultrasound, CT scan of the abdomen and pelvis, andor MRI of the liver, demonstrate multiple hepatic lesions consistent with metastatic disease.  Differential diagnosis includes primary liver cancer, benign liver tumors, and cirrhosis.  Diagnosis of liver metastasis confirmed based on imaging findings, correlation with primary cancer history, and clinical presentation.  Treatment plan includes discussion of palliative care options, systemic chemotherapy, targeted therapy, hepatic arterial infusion chemotherapy, radiofrequency ablation, andor surgical resection depending on the extent of disease, patient performance status, and primary tumor type.  Patient education provided regarding prognosis, treatment options, and potential side effects.  Referral made to oncology, hepatology, andor palliative care as appropriate.  Follow-up scheduled for ongoing monitoring and management of liver metastasis.  ICD-10 code C78.7 Secondary malignant neoplasm of liver and intrahepatic bile ducts assigned.  Medical billing codes will reflect evaluation and management services, imaging studies, laboratory tests, and procedures performed.